PRTN3 and rheumatoid arthritis: Another issue raised by van Dongen et al. [115] and already reported by others [19] concerns the beneficial effect of MTX in delaying the progression to RA in ACPA-positive undifferentiated arthritis (UA) but not in ACPA-negative UA.